Cargando…

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis

Recently, sirolimus, an inhibitor of mammalian target of rapamycin, was reported to decrease chylous effusion in patients with lymphangioleimyomatosis (LAM). We herein report a case of a 34-year-old woman with LAM who developed refractory chylothorax and chylous ascites during sirolimus therapy. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namba, Masashi, Masuda, Takeshi, Nakamura, Takashi, Horimasu, Yasushi, Miyamoto, Shintaro, Nakashima, Taku, Iwamoto, Hiroshi, Fujitaka, Kazunori, Hamada, Hironobu, Hattori, Noboru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790722/ https://www.ncbi.nlm.nih.gov/pubmed/29021448 http://dx.doi.org/10.2169/internalmedicine.8645-16

Ejemplares similares

Chronic Intestinal Pseudo-obstruction and Orthostatic Hypotension Associated with Small Cell Lung Cancer that Improved with Tumor Reduction after Chemoradiotherapy
por: Izumi, Yusuke, et al.
Publicado: (2017)

Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosis
por: Shioya, Sachiko, et al.
Publicado: (2018)

Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
por: Horimasu, Yasushi, et al.
Publicado: (2021)

Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
por: Takahashi, Hiroshi, et al.
Publicado: (2021)

AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2017)

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report
por: Nakao, Satoshi, et al.
Publicado: (2019)

High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery
por: Takao, Shun, et al.
Publicado: (2019)

Performance Status Is a Risk Factor for Depression before the Diagnosis of Lung Cancer Patients
por: Miwata, Kei, et al.
Publicado: (2018)

D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report
por: Matsumoto, Yu, et al.
Publicado: (2021)

Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
por: Ito, Noriaki, et al.
Publicado: (2021)

Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells
por: Daido, Wakako, et al.
Publicado: (2023)

Inhibition of PAI‐1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer‐associated fibroblasts
por: Masuda, Takeshi, et al.
Publicado: (2019)

Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
por: Takao, Shun, et al.
Publicado: (2021)

Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition
por: Tokumo, Kentaro, et al.
Publicado: (2023)

Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
por: Shimoji, Kiyofumi, et al.
Publicado: (2023)

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis
por: Hamai, Kosuke, et al.
Publicado: (2016)

Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2018)

Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma
por: Okumoto, Joe, et al.
Publicado: (2020)

Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports
por: Watari, Naokazu, et al.
Publicado: (2021)

Two Cases of Cranial Nerve Metastasis Treated with Radiotherapy and Chemotherapy in Patients with Lung Adenocarcinoma
por: Kobayashi, Erika, et al.
Publicado: (2020)

IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
por: Nakanishi, Yu, et al.
Publicado: (2021)

Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid Arthritis
por: Ito, Noriaki, et al.
Publicado: (2022)

Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis
por: Yamada, Takahiro, et al.
Publicado: (2019)

Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2020)

Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reports
por: Takao, Shun, et al.
Publicado: (2020)

A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia: A proof-of-concept study
por: Horimasu, Yasushi, et al.
Publicado: (2021)

First‐line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutations
por: Ito, Noriaki, et al.
Publicado: (2022)

Preserved ratio impaired spirometry with or without restrictive spirometric abnormality
por: Miura, Shinichiro, et al.
Publicado: (2023)

Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis
por: Aghaeimeybodi, Fatemeh, et al.
Publicado: (2019)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis
por: Steagall, Wendy K., et al.
Publicado: (2023)

Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice
por: Miwata, Kei, et al.
Publicado: (2018)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Quantitative analysis of computed tomography of the lungs in patients with lymphangioleiomyomatosis treated with sirolimus
por: Ko, Yuki, et al.
Publicado: (2020)

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
por: Shimoji, Kiyofumi, et al.
Publicado: (2020)

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
por: Wakabayashi, Yu, et al.
Publicado: (2020)

Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia
por: Matsumoto, Yu, et al.
Publicado: (2021)

Successful Sirolimus Treatment of Lymphangioleiomyomatosis in a Hepatitis B Virus Carrier
por: Sonobe, Shoko, et al.
Publicado: (2018)

Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
por: Neurohr, Claus, et al.
Publicado: (2011)

Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study
por: Zhan, Yongzhong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jslptfjqjr6jng17ctdd1md1pd